Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985
- PMID: 16398622
- DOI: 10.5694/j.1326-5377.2006.tb00086.x
Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985
Abstract
Objectives: To measure the incidence of treated non-melanoma skin cancer (NMSC) in Australia in 2002 and investigate trends since 1985 by histological type, sex, age group, latitude and skin type.
Design: Face-to-face survey between 1 January and 31 December 2002 using stratified sampling of households to identify people treated for skin cancer in the previous 12 months. Self-reported diagnoses were confirmed with treatment providers. Data from similar surveys conducted in 1985, 1990 and 1995 were used to assess trends.
Setting: Whole of Australia (population 19.6 million).
Participants: Of 57 215 people interviewed, 4098 said they had been treated for skin cancer in the past year and 3198 gave permission for their diagnoses to be confirmed with their doctor.
Results: 817 people were confirmed as having at least one skin cancer treated in the past year. The age-standardised rate per 100 000 population for NMSC was 1170, for basal cell carcinoma (BCC) 884, and for squamous cell carcinoma (SCC) 387. The estimated number of NMSC cases in Australia for 2002 was 374 000. Cumulative risks to age 70 years of having at least one NMSC were 70% for men and 58% for women. Rates of BCC and SCC have increased since 1985, and the increases greatest for people aged 60 years and older; rates for those younger than 60 years have stabilised.
Conclusions: The incidence of treated NMSC in Australia in 2002 was more than five times the incidence of all other cancers combined. Although the overall NMSC rates have risen since 1985, the stabilisation of rates for people younger than 60 years who were exposed to skin cancer prevention programs in their youth highlights the importance of maintaining and strengthening these programs.
Similar articles
-
Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect?Int J Cancer. 1998 Oct 5;78(2):144-8. doi: 10.1002/(sici)1097-0215(19981005)78:2<144::aid-ijc3>3.0.co;2-z. Int J Cancer. 1998. PMID: 9754642
-
Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.Cancer. 1996 Jun 15;77(12):2489-95. doi: 10.1002/(SICI)1097-0142(19960615)77:12<2489::AID-CNCR11>3.0.CO;2-O. Cancer. 1996. PMID: 8640697
-
The burden of non-melanoma skin cancers in Auckland, New Zealand.Australas J Dermatol. 2018 Aug;59(3):210-213. doi: 10.1111/ajd.12751. Epub 2018 Jan 19. Australas J Dermatol. 2018. PMID: 29350397
-
Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight.Adv Exp Med Biol. 2008;624:89-103. doi: 10.1007/978-0-387-77574-6_8. Adv Exp Med Biol. 2008. PMID: 18348450 Review.
-
Epidemiology of skin cancer.Adv Exp Med Biol. 2014;810:120-40. doi: 10.1007/978-1-4939-0437-2_7. Adv Exp Med Biol. 2014. PMID: 25207363 Review.
Cited by
-
Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER).Lancet. 2013 May 25;381(9880):1835-43. doi: 10.1016/S0140-6736(12)62166-7. Epub 2013 May 7. Lancet. 2013. PMID: 23660123 Free PMC article. Clinical Trial.
-
Non-Melanoma Skin Cancers: Biological and Clinical Features.Int J Mol Sci. 2020 Jul 29;21(15):5394. doi: 10.3390/ijms21155394. Int J Mol Sci. 2020. PMID: 32751327 Free PMC article. Review.
-
Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents.J Eur Acad Dermatol Venereol. 2019 Dec;33 Suppl 8(Suppl 8):6-10. doi: 10.1111/jdv.15967. J Eur Acad Dermatol Venereol. 2019. PMID: 31833607 Free PMC article.
-
Metastatic cutaneous squamous cell carcinoma to the parotid: Adjuvant radiotherapy and treatment outcomes.J Med Radiat Sci. 2023 Jun;70(2):161-170. doi: 10.1002/jmrs.650. Epub 2023 Feb 15. J Med Radiat Sci. 2023. PMID: 36790039 Free PMC article.
-
Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome.EJHaem. 2021 Dec 13;3(1):129-138. doi: 10.1002/jha2.366. eCollection 2022 Feb. EJHaem. 2021. PMID: 35846218 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous